Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PR104 in Small Cell Lung Cancer
NCT00544674Phase 2Terminated
- Sponsor
- Proacta Inc.
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PR-104 in small cell lung cancer (SCLC), sponsored by Proacta Inc.. Started Aug 2007; status: terminated.
02
Drugs
PR-104
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00544674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544674.